Concourse Financial Group Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-345
Closed -$85.3K 1630
2024
Q4
$85.3K Buy
345
+19
+6% +$4.58K ﹤0.01% 1001
2024
Q3
$79.6K Buy
326
+30
+10% +$6.7K ﹤0.01% 1021
2024
Q2
$56.7K Buy
296
+11
+4% +$2.23K ﹤0.01% 1127
2024
Q1
$56.4K Buy
285
+2
+0.7% +$366 ﹤0.01% 1139
2023
Q4
$48.7K Buy
283
+65
+30% +$9.99K ﹤0.01% 1144
2023
Q3
$32.2K Sell
218
-17
-7% -$3.07K ﹤0.01% 1263
2023
Q2
$51.3K Sell
235
-17
-7% -$3.79K ﹤0.01% 1083
2023
Q1
$55.2K Sell
252
-18
-7% -$3.9K ﹤0.01% 1055
2022
Q4
$56.2K Sell
270
-3
-1% -$659 ﹤0.01% 1028
2022
Q3
$60K Buy
273
+12
+5% +$2.73K 0.01% 886
2022
Q2
$55K Sell
261
-12
-4% -$2.56K ﹤0.01% 1047
2022
Q1
$66K Sell
273
-57
-17% -$13.8K ﹤0.01% 1035
2021
Q4
$86K Buy
330
+16
+5% +$4.15K ﹤0.01% 1073
2021
Q3
$83K Buy
314
+14
+5% +$3.83K 0.01% 1080
2021
Q2
$74K Buy
300
+29
+11% +$6.1K ﹤0.01% 1128
2021
Q1
$53K Sell
271
-19
-7% -$3.81K ﹤0.01% 1205
2020
Q4
$62K Sell
290
-67
-19% -$13.4K ﹤0.01% 1086
2020
Q3
$61K Buy
357
+198
+125% +$36.6K 0.01% 982
2020
Q2
$31K Sell
159
-9
-5% -$1.47K ﹤0.01% 1135
2020
Q1
$25K Sell
168
-185
-52% -$29.5K ﹤0.01% 1159
2019
Q4
$55K Buy
353
+162
+85% +$23.3K 0.01% 915
2019
Q3
$26K Buy
191
+129
+208% +$16.9K 0.01% 874
2019
Q2
$8K Hold
62
﹤0.01% 1571
2019
Q1
$6K Hold
62
﹤0.01% 1691
2018
Q4
$7K Sell
62
-17
-22% -$1.82K ﹤0.01% 1543
2018
Q3
$9K Buy
+79
New +$8.65K ﹤0.01% 1163

Other funds holding RMD

Concourse Financial Group Securities's RMD Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of ResMed (RMD) in Q1 2025, closing a stake of 345 shares — an estimated $85.3K sold.

Concourse Financial Group Securities first reported a position in RMD in Q3 2018 and held it in 26 quarters. The position peaked at $86K in Q4 2021. 886 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 345 ResMed shares in Q1 2025, an estimated $85.3K.
  • Concourse Financial Group Securities first reported a position in ResMed in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's ResMed position peaked at $86K in Q4 2021.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.